Literature DB >> 19816400

Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs).

Andreas Reinisch1, Dirk Strunk.   

Abstract

The umbilical cord is a rich source for progenitor cells with high proliferative potential including mesenchymal stromal cells (also termed mesenchymal stem cells, MSCs) and endothelial colony forming progenitor cells (ECFCs). Both cell types are key players in maintaining the integrity of tissue and are probably also involved in regenerative processes and tumor formation. To study their biology and function in a comparative manner it is important to have both cells types available from the same donor. It may also be beneficial for regenerative purposes to derive MSCs and ECFCs from the same tissue. Because cellular therapeutics should eventually find their way from bench to bedside we established a new method to isolate and further expand progenitor cells without the use of animal protein. Pooled human platelet lysate (pHPL) replaced fetal bovine serum in all steps of our protocol to completely avoid contact of the cells to xenogeneic proteins. This video demonstrates a methodology for the isolation and expansion of progenitor cells from one umbilical cord. All materials and procedures will be described.

Entities:  

Mesh:

Year:  2009        PMID: 19816400      PMCID: PMC3164069          DOI: 10.3791/1525

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  4 in total

1.  Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.

Authors:  Andreas Reinisch; Christina Bartmann; Eva Rohde; Katharina Schallmoser; Vesna Bjelic-Radisic; Gerhard Lanzer; Werner Linkesch; Dirk Strunk
Journal:  Regen Med       Date:  2007-07       Impact factor: 3.806

2.  Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.

Authors:  Andreas Reinisch; Nicole A Hofmann; Anna C Obenauf; Karl Kashofer; Eva Rohde; Katharina Schallmoser; Karin Flicker; Gerhard Lanzer; Werner Linkesch; Michael R Speicher; Dirk Strunk
Journal:  Blood       Date:  2009-03-25       Impact factor: 22.113

3.  Phenotypic characterization and preclinical production of human lineage-negative cells for regenerative stem cell therapy.

Authors:  Dirk Strunk; Eva Rohde; Gerhard Lanzer; Werner Linkesch
Journal:  Transfusion       Date:  2005-03       Impact factor: 3.157

4.  Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.

Authors:  Katharina Schallmoser; Christina Bartmann; Eva Rohde; Andreas Reinisch; Karl Kashofer; Elke Stadelmeyer; Camilla Drexler; Gerhard Lanzer; Werner Linkesch; Dirk Strunk
Journal:  Transfusion       Date:  2007-08       Impact factor: 3.157

  4 in total
  29 in total

Review 1.  Crosstalk between Stem and Progenitor Cellular Mediators with Special Emphasis on Vasculogenesis.

Authors:  Rokhsareh Rohban; Barbara Prietl; Thomas R Pieber
Journal:  Transfus Med Hemother       Date:  2017-06-06       Impact factor: 3.747

2.  Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.

Authors:  Andreas Reinisch; Nathalie Etchart; Daniel Thomas; Nicole A Hofmann; Margareta Fruehwirth; Subarna Sinha; Charles K Chan; Kshemendra Senarath-Yapa; Eun-Young Seo; Taylor Wearda; Udo F Hartwig; Christine Beham-Schmid; Slave Trajanoski; Qiong Lin; Wolfgang Wagner; Christian Dullin; Frauke Alves; Michael Andreeff; Irving L Weissman; Michael T Longaker; Katharina Schallmoser; Ravindra Majeti; Dirk Strunk
Journal:  Blood       Date:  2014-11-18       Impact factor: 22.113

3.  Intrauterine Hyperglycemia Is Associated with an Impaired Postnatal Response to Oxidative Damage.

Authors:  Jessica N Tozour; Fabien Delahaye; Masako Suzuki; Aaron Praiss; Yongmei Zhao; Lingguang Cai; Hye J Heo; John M Greally; Francine Hughes
Journal:  Stem Cells Dev       Date:  2018-04-26       Impact factor: 3.272

Review 4.  Stem cells and regenerative medicine: accomplishments to date and future promise.

Authors:  Karim Y Helmy; Shyam A Patel; Kimberly Silverio; Lillian Pliner; Pranela Rameshwar
Journal:  Ther Deliv       Date:  2010-11

5.  Phenotypic and functional characterization of endothelial colony forming cells derived from human umbilical cord blood.

Authors:  Nutan Prasain; J Luke Meador; Mervin C Yoder
Journal:  J Vis Exp       Date:  2012-04-13       Impact factor: 1.355

6.  Flk-1⁺Sca-1⁻ mesenchymal stem cells: functional characteristics in vitro and regenerative capacity in vivo.

Authors:  Yugang Li; Enshan Pan; Yu Wang; Xiaoguang Zhu; Anyang Wei
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Down regulation of ITGA4 and ITGA5 genes after formation of 3D spherules by human Wharton's jelly stem cells (hWJSCs).

Authors:  Zohreh Mostafavi-Pour; Mohammad Reza Ashrafi; Tahereh Talaei-Khozani
Journal:  Mol Biol Rep       Date:  2018-02-06       Impact factor: 2.316

8.  Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation.

Authors:  Eva Rohde; Katharina Schallmoser; Andreas Reinisch; Nicole A Hofmann; Thomas Pfeifer; Eleonore Fröhlich; Gerald Rechberger; Gerhard Lanzer; Dagmar Kratky; Dirk Strunk
Journal:  Cytotherapy       Date:  2010-12-03       Impact factor: 5.414

9.  Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo.

Authors:  Nicole A Hofmann; Anna Ortner; Rodrigo O Jacamo; Andreas Reinisch; Katharina Schallmoser; Rokhsareh Rohban; Nathalie Etchart; Margareta Fruehwirth; Christine Beham-Schmid; Michael Andreeff; Dirk Strunk
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

10.  Identification of an effective early signaling signature during neo-vasculogenesis in vivo by ex vivo proteomic profiling.

Authors:  Rokhsareh Rohban; Andreas Reinisch; Nathalie Etchart; Katharina Schallmoser; Nicole A Hofmann; Krisztina Szoke; Jan E Brinchmann; Ehsan Bonyadi Rad; Eva Rohde; Dirk Strunk
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.